CD274 and neoplasm: The implementation of anti‐PD‐1‐PD‐L‐1 agents with neoadjuvant components, such as poly(I:C) significantly reduced the risk of metastasis and tumor burden in 4T1 and 4T2‐infected mouse models [125].